Intelligent supervision system and method based on medical insurance data and electronic equipment

Through an intelligent supervision system based on medical insurance data, matching the information of drug purchase users and generating a list of compliant drugs, the problem of unutilized potential value in medical insurance data is solved, real-time monitoring of drug purchase behavior and reducing drug abuse is achieved, and the improvement of improved The quality of pharmacy service.

CN119048189APending Publication Date: 2024-11-29HANGZHOU JINGWEISHENG INTELLIGENT TECH CO LTD
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202410462649.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-04-17
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

The existing technology cannot deeply explore the potential value in medical insurance data, resulting in drug purchasers who may purchase non-compliant drugs, which in turn leads to drug abuse.

Method used

Design an intelligent supervision system based on medical insurance data, including data storage module, fixed-point management module and data display module. By matching the information of drug purchase users and the information of comparison users, a list of compliant drugs is generated and displayed to the monitoring personnel through a graphical interface. Monitor drug purchases in real time, eliminate ineffective drugs, and reduce drug abuse.

Benefits of technology

Real-time monitoring and compliant drug recommendations for drug purchase users are achieved, improving the service level and service quality of pharmacies, reducing drug abuse, and ensuring that users purchase appropriate drugs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119048189A_ABST
    Figure CN119048189A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of medical insurance data processing, in particular to an intelligent supervision system and method based on medical insurance data and electronic equipment, and the system comprises a data storage module which is used for storing a plurality of groups of contrast user information and medical insurance data corresponding to the contrast user information; the fixed-point management module is used for acquiring medicine purchasing user information, screening the medicine purchasing user information in contrast user information, and judging whether matched contrast user information can be screened or not; if the corresponding contrast user can be matched, acquiring corresponding medical insurance data according to the contrast user information, acquiring demand information according to the medicine purchasing user information, and generating a compliance medicine list according to the demand information and the medical insurance data; and the data display module is used for displaying the compliance drug list to monitoring personnel in the form of a graphical interface. According to the invention, pharmacy medical insurance medicine purchasing supervision is improved, and the abuse degree of medicines is reduced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of medical insurance data processing, and in particular to an intelligent supervision system, method and electronic device based on medical insurance data. Background Art

[0002] With the rapid development of electronic information technology, all walks of life in society are carrying out their own information construction and transformation with the goal of achieving office automation. In the field of medical and health care, due to the development of the national economy and the improvement of people's living standards, people's demand for medical and health services is becoming more and more intense.

[0003] Current medical services include hospitals, outpatient clinics and pharmacies to meet people's medical needs. The platform realizes the information management of medical insurance data and designated medical insurance units, and combines geographic technology to provide a scientific basis for the supervision and management of medical insurance expenses and designated medical insurance units, allowing medical insurance terminals to exchange and process data through the Internet in a safe and efficient big data environment.

[0004] However, current technical knowledge to achieve data exchange cannot deeply tap the potential value in medical insurance data. For example, when a user goes to a pharmacy to buy medicine, there is no supervision on the user's purchase of medicine, which may cause the user to buy some non-compliant drugs, leading to some drug abuse. Summary of the invention

[0005] In order to improve the supervision of medical insurance drug purchases in pharmacies and reduce the degree of drug abuse, the present application provides an intelligent supervision system, method and electronic equipment based on medical insurance data.

[0006] In the first aspect, the present application provides an intelligent supervision system based on medical insurance data, which adopts the following technical solutions: An intelligent supervision system based on medical insurance data, comprising: A data storage module, the data storage module is used to store several groups of control user information and medical insurance data corresponding to the control user information; A fixed-point management module, wherein the fixed-point management module is connected to the data storage module through a network to obtain the control user information and the medical insurance data, and the fixed-point management module is used to obtain drug purchasing user information, filter the drug purchasing user information among the control user information, and determine whether matching control user information can be filtered out; If a corresponding control user can be matched, the corresponding medical insurance data is obtained according to the control user information, and the demand information is obtained according to the drug purchasing user information, and a list of compliant drugs is generated according to the demand information and the medical insurance data; A data display module, wherein the data display module is connected to the fixed-point management module through a network to receive the compliant drug list, and the data display module is used to display the compliant drug list to monitoring personnel in a graphical interface.

[0007] By adopting the above technical solution, the fixed-point management module matches the acquired user information with the reference user information to determine whether the corresponding reference user information can be matched in the data storage module. If the corresponding reference user can be matched, the corresponding medical insurance data is obtained based on the reference user information, and the demand information is obtained based on the drug purchasing user information, and a list of compliant drugs is generated based on the demand information and the medical insurance data, and the compliant drug list is displayed to the monitoring personnel in a graphical interface, so that the user's drug purchase can be monitored in real time and traced, which is convenient for subsequent drug testing and reduces the degree of drug abuse.

[0008] In one embodiment, it further includes a drug purchase detection module, which is connected to the fixed-point management module through a network to receive the compliant drug list, and is used to sequentially obtain temporary drug purchase data according to the compliant drug list, obtain previous drug purchase data corresponding to the user information, and determine whether the previous drug purchase data is similar to the temporary drug purchase data; If the previous drug purchase data is similar to the temporary drug purchase data, the drug purchase interval is obtained based on the previous drug purchase data and the temporary drug purchase data, and it is determined whether the drug purchase interval is within a preset range. If the drug purchase interval is within the preset range, it is determined that the drug type corresponding to the temporary drug purchase data is not effective, the drug type is marked, and it is automatically removed from the compliant drug list.

[0009] By adopting the above technical solution, the drug purchase detection module judges the drug types in the compliant drug list in turn to determine whether they are effective for the user who purchases the drug. When the drug is not effective for the user who purchases the drug, the drug is removed from the compliant drug list, thereby facilitating the staff to select suitable drugs for the user who purchases the drug, thereby improving the service level and service quality of the pharmacy and making it more convenient for the general public to seek medical treatment and purchase drugs.

[0010] In one embodiment, a drug monitoring module is further included, the drug purchase detection module is further used to generate a marking signal based on marking the drug type, and the drug monitoring module is connected to the drug purchase detection module network to receive the marking signal of the drug type; The drug monitoring module is used to obtain several drug types marked by the drug purchase detection module according to the marking signal, and obtain the drug marking times of each drug type, and compare the drug marking times in turn to see whether they exceed the preset times; If the drug marking times exceed a preset times, the drug monitoring module generates a detection signal and reminds the staff to detect the drug type according to the detection signal.

[0011] By adopting the above technical solution, the drug monitoring module counts the number of drug markings of the drug type and compares the number of drug markings with the preset number. When the number of drug markings exceeds the preset number, it means that the drug type cannot treat the body of the user who purchases the drug. Therefore, by generating a detection signal, the drug store can reduce the purchase of the drug type, thereby improving the monitoring effect of the drug store and making it convenient for the general public to seek medical treatment and purchase drugs.

[0012] In one embodiment, the fixed-point management module includes a data comparison unit, a data storage unit, and a list processing unit, wherein the data comparison unit is connected to the data storage unit via a network, and the data comparison unit is connected to the list processing unit via a network; Wherein, the data comparison unit screens the drug purchasing user information in the control user information, and determines whether matching control user information can be screened out; If the corresponding control user information cannot be matched, the data storage unit obtains the demand information according to the drug purchasing user information, obtains the drug purchasing type according to the demand information, and records and stores the drug purchasing type; If the corresponding control user can be matched, the list processing unit obtains the corresponding medical insurance data based on the control user information, obtains the demand information based on the drug purchasing user information, and obtains the contraindicated drug information based on the demand information based on the medical insurance data, and generates the compliant drug list based on the contraindicated drug information.

[0013] In one embodiment, the fixed-point management module further includes a fee control unit and a first warning unit connected to the fee control unit through a network; The cost control unit is connected to the list processing unit through a network to receive the compliant drug list and obtain corresponding drug price information, compare the price value of the drug price information with the corresponding preset price, and determine whether the price value is similar to the preset price; If the price value is not similar to the preset price, the first warning unit generates a warning signal and sends an abnormal instruction according to the warning signal to remind the monitoring personnel.

[0014] By adopting the above technical solution, the cost control unit is connected to the list processing unit network to receive the drug price information of the compliant drug list, and compares the price value of the drug price information with the corresponding preset price, and determines whether the price value is similar to the preset price; if the price value is not similar to the preset price, the first warning unit generates a warning signal, and sends an abnormal instruction based on the warning signal to remind the monitoring personnel to review the pharmacy in time, so as to monitor the price of the drug in real time, which can facilitate users' purchases and improve the overall supervision effect of the pharmacy.

[0015] In one embodiment, the fixed-point management module further includes a drug purchase analysis unit and a second warning unit connected to the drug purchase analysis unit through a network; Wherein, the drug purchase analysis unit is used to obtain all the treatment diseases corresponding to the area to be tested, and the area to be tested includes a number of drug stores to be tested; Obtaining the number of pharmacies to be tested according to the treatment disease, and comparing the number of pharmacies to be tested with a preset number, wherein the number of pharmacies to be tested represents the number of pharmacies to be tested that have the same treatment disease; Analyze the environmental conditions of all the pharmacies to be tested to obtain the environmental type, and determine whether all the pharmacies to be tested are in the same environment; If all the pharmacies to be tested are in the same type of environment, the second warning unit generates a first response signal and performs a first level of protection according to the first response signal; If all the pharmacies to be tested are not in the same environment, the second warning unit generates a second response signal and performs secondary protection according to the second response signal.

[0016] By adopting the above technical solution, when a large area of ​​treatment symptoms appear in the tested area, it is necessary to timely analyze whether it is related to the external environment, so as to obtain corresponding response measures, improve the public's utilization of resources in hospitals and pharmacies, and solve the corresponding treatment symptoms as soon as possible.

[0017] In the second aspect, the present application provides an intelligent supervision method based on medical insurance data, which adopts the following technical solutions: An intelligent supervision method based on medical insurance data includes the following steps: Acquire drug purchasing user information, filter the drug purchasing user information in the control user information, and determine whether matching control user information can be found; If a corresponding control user can be matched, the corresponding medical insurance data is obtained according to the control user information, and the demand information is obtained according to the drug purchasing user information, and a list of compliant drugs is generated according to the demand information and the medical insurance data; The list of compliant drugs and the types of purchased drugs are displayed to monitoring personnel in a graphical interface.

[0018] In one embodiment, after obtaining the drug type matching the drug purchasing user according to the compliant drug list, the following steps are also included: Regularly obtain drug storage data corresponding to a number of drug types; Obtaining estimated sales data based on a preset analysis model, obtaining estimated drug inventory based on the estimated sales data and the drug storage data, and comparing the estimated drug inventory with a preset inventory; If the estimated drug inventory is less than the preset inventory, a corresponding purchase signal is generated so that the drug store to be tested increases the drug storage data of the corresponding drug type according to the purchase signal.

[0019] By adopting the above technical scheme, the estimated drug inventory is obtained for the drug storage data of each drug type and the estimated sales data obtained based on the preset analysis model, and then it is determined whether the drugs of this drug type need to be restocked. When the estimated drug inventory is less than the preset inventory, a corresponding restocking signal is generated so that the pharmacy to be tested can increase the drug storage data of the corresponding drug type according to the restocking signal, so that when the public buys drugs in batches, there will be sufficient drugs, thereby improving the service level and service quality of pharmacies and making it convenient for the general public to seek medical treatment and buy drugs.

[0020] In one embodiment, after the periodic acquisition of the drug storage data corresponding to the drug types, the following steps are also included: Obtaining the actual sales volume corresponding to the drug type in sequence, and obtaining the difference data quantity according to the actual sales volume and the estimated sales data, and determining whether the difference data quantity is greater than the preset data quantity; If the number of difference data is greater than the preset number of data, the treatment condition is obtained according to the drug type corresponding to the actual sales volume, and a corresponding symptomatic replenishment signal is generated according to the treatment condition, so as to obtain several symptomatic drug types according to the symptomatic replenishment signal.

[0021] By adopting the above technical scheme, for different types of drugs, there may be a period of time when large quantities are sold. In order to analyze these abnormal data and obtain corresponding results in time, it is judged whether the number of difference data is greater than the preset number of data. If the number of difference data is greater than the preset number of data, the treatment disease is obtained according to the drug type corresponding to the actual sales volume, and the corresponding symptomatic replenishment signal is generated according to the treatment disease, so as to obtain several symptomatic drug types according to the symptomatic replenishment signal, so as to enable the pharmacy to replenish the drugs corresponding to the treatment disease in time, thereby improving the service level and service quality of the pharmacy and facilitating the general public to seek medical treatment and purchase drugs.

[0022] In a third aspect, the present application provides an electronic device, which adopts the following technical solution: An electronic device, comprising a memory and a processor coupled to each other, wherein the memory stores a computer program that can be run on the processor; When the computer program is executed by the processor, the intelligent supervision method based on medical insurance data as described in the second aspect is implemented.

[0023] In summary, the present application includes at least one of the following beneficial technical effects: 1. The fixed-point management module matches the acquired user information with the reference user information, and determines whether the corresponding reference user information can be matched in the data storage module. If the corresponding reference user can be matched, the corresponding medical insurance data is obtained according to the reference user information, and the demand information is obtained according to the drug purchasing user information, and a list of compliant drugs is generated according to the demand information and the medical insurance data, and the compliant drug list and the purchased drug types are displayed to the monitoring personnel in a graphical interface, so that the user's drug purchase can be monitored in real time and left a trace, which is convenient for subsequent drug testing and reduces the degree of drug abuse; 2. The drug purchase detection module judges the drug types in the compliant drug list in turn to determine whether they are effective for the drug purchaser. If they are not effective for the drug purchaser, the drug is removed from the compliant drug list, which makes it easier for the staff to select the appropriate drug for the drug purchaser, thereby improving the service level and quality of the pharmacy and facilitating the general public to seek medical treatment and purchase drugs; 3. Obtain the estimated drug inventory for each drug type based on the drug storage data and the estimated sales data obtained based on the preset analysis model, and then determine whether the drug of this drug type needs to be restocked. When the estimated drug inventory is less than the preset inventory, a corresponding restocking signal is generated so that the pharmacy to be tested can increase the drug storage data of the corresponding drug type according to the restocking signal, so that when the public buys drugs in batches, there will be sufficient drugs, thereby improving the service level and service quality of pharmacies and making it convenient for the general public to seek medical treatment and purchase drugs. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] Figure 1 It is a schematic diagram of the structure of an intelligent supervision system based on medical insurance data provided in an embodiment of the present application; Figure 2 It is a partial structural diagram of a fixed-point management module provided in an embodiment of the present application; Figure 3 It is a schematic diagram of another part of the structure of the fixed-point management module provided in an embodiment of the present application; Figure 4 It is a block diagram of the intelligent supervision method based on medical insurance data provided by an embodiment of the present application; Figure 5 is a method block diagram of another embodiment provided by the embodiment of the present application; Figure 6 It is a structural block diagram of the detection device provided in this embodiment.

[0025] Explanation of the accompanying drawings: 10. Data storage module; 20. Fixed-point management module; 21. Data comparison unit; 22. Data storage unit; 23. List processing unit; 24. Cost control unit; 25. First warning unit; 26. Drug purchase analysis unit; 27. Second warning unit; 30. Data display module; 40. Drug purchase detection module; 50. Drug monitoring module; 61. Memory; 62. Processor; 621. Computer program. DETAILED DESCRIPTION

[0026] To more clearly understand the purpose, technical solutions and advantages of the present application, the present application is described and illustrated below in conjunction with the accompanying drawings and embodiments. However, it should be understood by those of ordinary skill in the art that the present application can be implemented without these details. In some cases, in order to avoid unnecessary descriptions that make various aspects of the present application obscure, well-known methods, processes, systems, components and / or circuits that have been described at a higher level will not be described in detail. For those of ordinary skill in the art, it is obvious that various changes can be made to the embodiments disclosed in the present application, and without departing from the principles and scope of the present application, the general principles defined in the present application can be applied to other embodiments and application scenarios. Therefore, the present application is not limited to the embodiments shown, but conforms to the broadest scope consistent with the scope claimed for protection of the present application.

[0027] The embodiment of the present application discloses an intelligent supervision system based on medical insurance data.

[0028] like Figure 1As shown, the intelligent supervision system based on medical insurance data includes a data storage module 10, a fixed-point management module 20 and a data display module 30. The data storage module 10 is used to store several groups of control user information and medical insurance data corresponding to the control user information. The fixed-point management module 20 is connected to the data storage module 10 through a network to obtain the control user information and the medical insurance data.

[0029] The fixed-point management module 20 is used to obtain the drug purchasing user information, screen the drug purchasing user information in the control user information, and determine whether the matching control user information can be screened. If the corresponding control user can be matched, the corresponding medical insurance data is obtained according to the control user information, and the demand information is obtained according to the drug purchasing user information, and the compliant drug list is generated according to the demand information and the medical insurance data. The data display module 30 is connected to the fixed-point management module 20 network to receive the compliant drug list, and the data display module 30 is used to display the compliant drug list to the monitoring personnel in a graphical interface.

[0030] Among them, the control user information represents the user information stored in the hospital medical insurance database, and the medical insurance data represents the medical insurance data corresponding to the control user. The data storage module 10 mainly stores the information of several users and the corresponding medical insurance data. These data can be directly shared in the hospital medical insurance system, or they can be obtained by entering the hospital medical insurance system and storing these data. Of course, in order to make the data more accurate, the data stored in the data storage module 10 needs to be updated in real time.

[0031] In addition, the drug purchase user information represents the user information who goes to the drugstore to buy drugs. This drug purchase user information can be obtained by the fixed-point management module 20 through the user directly swiping his own electronic medical insurance card or medical insurance card. The drug purchase user information mainly represents the identity information of the drug purchase user. The demand information represents the drug purchase demand of the drug purchase user, such as where the body is uncomfortable or what medicine needs to be purchased.

[0032] It should be noted here that the data display module 30 receives the compliant drug list sent by the fixed-point management module and displays the compliant drug list to the monitoring personnel, so that the monitoring personnel can review the drugs in the compliant drug list. Specifically, the compliant drug list can be displayed to the monitoring personnel through a display screen.

[0033] In addition, if the fixed-point management module 20 fails to match the corresponding control user in the control user information, it means that the user has no record of using medical insurance to purchase medicines or the data has not been updated. The data can be updated first. If it cannot be found, the user's medicine purchase information can be recorded to facilitate subsequent drug supervision.

[0034] Reference Figure 2In another embodiment, the fixed-point management module 20 includes a data comparison unit 21, a data storage unit 22 and a list processing unit 23, the data comparison unit 21 is connected to the data storage unit 22 via a network, and the data comparison unit 21 is connected to the list processing unit 23 via a network.

[0035] Among them, the data comparison unit 21 screens the drug purchasing user information in the control user information, and determines whether the matching control user information can be screened. If the corresponding control user information cannot be matched, the data storage unit 22 obtains the demand information based on the drug purchasing user information, obtains the drug purchase type based on the demand information, and records and stores the drug purchase type. If the corresponding control user can be matched, the list processing unit 23 obtains the corresponding medical insurance data based on the control user information, obtains the demand information based on the drug purchasing user information, and obtains the contraindicated drug information based on the demand information based on the medical insurance data, and generates a compliant drug list based on the contraindicated drug information.

[0036] Among them, the type of medicine purchased represents the type of medicine obtained based on the demand information of the user who purchased the medicine. Here, the type of medicine purchased needs to be recorded and stored to facilitate subsequent inquiries about the medicine. It should be noted here that before the person who purchases the medicine purchases the medicine, the pharmacy staff inquires the user who purchases the medicine according to the demand information, and records and stores the inquiry results in the fixed-point management module 20. Contraindicated drug information represents the information of medicines that the user who purchases the medicine cannot use. The types of contraindicated drugs corresponding to the contraindicated drug information are mainly obtained based on medical insurance data. In the previous medical data of the user who purchased the medicine, it can be known from the user's own situation that the user who purchased the medicine cannot use certain drugs. Therefore, when generating a list of compliant drugs for the user who purchased the medicine, these contraindicated drug information can be removed from the list of compliant drugs.

[0037] In another embodiment, the fixed-point management module 20 further includes a cost control unit 24 and a first warning unit 25 connected to the cost control unit 24 through a network. The cost control unit 24 is connected to the list processing unit 23 through a network to receive drug price information of the compliant drug list, and compare the price value of the drug price information with the corresponding preset price, and determine whether the price value is similar to the preset price. If the price value is not similar to the preset price, the first warning unit 25 generates a warning signal, and sends an abnormal instruction according to the warning signal to remind the drug purchasing user.

[0038] Among them, the drug price information represents the actual selling price of the drug in the list of compliant drugs, while the preset price represents the standard selling price of the drug.

[0039] The warning signal represents the signal generated by the first warning unit 25, and is mainly used to represent the warning signal generated when the selling price of the pharmacy is different from the preset price. After the first warning unit 25 generates the warning signal, it is necessary to send an instruction to the monitoring personnel that the pharmacy has abnormal prices.

[0040] Reference Figure 3 In another embodiment, the fixed-point management module 20 further includes a drug purchase analysis unit 26 and a second warning unit 27 connected to the drug purchase analysis unit 26 through a network. The drug purchase analysis unit 26 is used to obtain all therapeutic diseases corresponding to the area to be tested, and the area to be tested includes a number of drug stores to be tested. The number of drug stores to be tested is obtained based on the therapeutic disease, and the number of drug stores to be tested is compared with a preset number, wherein the number of drug stores to be tested represents the number of drug stores to be tested with the same therapeutic disease. The drug purchase analysis unit 26 is also used to analyze the environmental conditions of all drug stores to be tested to obtain the environmental type and determine whether all drug stores to be tested are in the same environment. If all drug stores to be tested are in the same environment, the second warning unit 27 generates a first response signal and performs a first-level protection according to the first response signal. If all drug stores to be tested are not in the same environment, the second warning unit 27 generates a second response signal and performs a second-level protection according to the second response signal.

[0041] Among them, the environment type represents the environment around the drugstore to be tested, including natural environment and artificial environment. The natural environment can be weather, and the artificial environment can be surrounding facilities, etc. The first response signal represents a response signal with a lower priority. Since it is the same environment, it means that the area to be tested is in the same treatment condition due to environmental factors. The first level of protection represents the protection measures generated based on the first response signal.

[0042] It should be noted here that the first-level protection mainly provides different protections for the natural environment and the man-made environment. For the natural environment, people in the tested area can be reminded to protect themselves. For the man-made environment, professional personnel are required to conduct inspections to eliminate the harm to the masses in a timely manner.

[0043] The second response signal represents a different environment, which may be a contagious disease, so it is necessary to respond to the second response signal in a timely manner. Therefore, secondary protection is generated based on the second response signal, thereby improving the safety protection of people in the tested area.

[0044] In order to enable buyers to purchase drugs that are more suitable for themselves, it is necessary to analyze the recommended drugs in the recommended drug list, and some drugs that have been taken in the early stage but have not shown any effect can be eliminated.

[0045] Reference Figure 1In another embodiment, the intelligent supervision system based on medical insurance data also includes a drug purchase detection module 40, which is connected to the fixed-point management module 20 through a network to receive a list of compliant drugs. The drug purchase detection module 40 is used to obtain temporary drug purchase data based on the compliant drug list in turn, and obtain previous drug purchase data corresponding to user information, and determine whether the previous drug purchase data is similar to the temporary drug purchase data.

[0046] If the previous drug purchase data is similar to the temporary drug purchase data, the drug purchase interval is obtained based on the previous drug purchase data and the temporary drug purchase data, and it is determined whether the drug purchase interval is within the preset range. If the drug purchase interval is within the preset range, it is determined that the drug type corresponding to the temporary drug purchase data is not effective, the drug type is marked, and it is automatically removed from the list of compliant drugs.

[0047] Among them, temporary drug purchase data represents drug data obtained based on the recommended drug list, and past drug purchase data represents the historical drug purchase records of the purchasing user, and the past drug purchase data is the most recent drug purchase data. The similarity between past drug purchase data and temporary drug purchase data is mainly to determine whether the type of drug purchased most recently is the same as the type of drug purchased this time. The specific way to determine the same is mainly to see whether the two drugs treat the same disease. If the past drug purchase data is not similar to the temporary drug purchase data, it means that the drug type does not need to be marked.

[0048] The drug purchase interval represents the time interval between the previous drug purchase data and the temporary drug purchase data, and the preset range is a range set in advance, which is used to determine whether the minimum time for the drug purchase user to recover from the last illness. The preset range can generally be set according to the demand information of the drug purchase user, specifically according to the specific treatment course of the drug purchase user. In this embodiment, the preset range is preferably set to 1 week.

[0049] It should be noted here that if the drug purchase interval is not within the preset range, the drug purchase detection module 40 does not process it, and the drug type does not need to be removed from the recommendation list.

[0050] Reference Figure 1 In another embodiment, the intelligent supervision system based on medical insurance data also includes a drug monitoring module 50, and the drug purchase detection module 40 is also used to generate a marking signal based on marking the drug type. The drug monitoring module 50 is connected to the drug purchase detection module 40 through a network to receive the marking signal of the drug type. The drug monitoring module 50 is used to obtain several drug types marked by the drug purchase detection module 40 based on the marking signal, and obtain the drug marking times of each drug type, and compare the drug marking times in turn to see if they exceed the preset times. If the drug marking times exceed the preset times, the drug monitoring module 50 generates a detection signal, and reminds the staff to detect the drug type based on the detection signal.

[0051] The marking signal indicates that the drug store has a poor effect and is marked, and the marking signal may be marked multiple times. The drug type indicates the drug type obtained by the drug monitoring module 50, which is mainly the drug type identified by obtaining the marking signal obtained by the drug purchase detection module 40.

[0052] The number of drug markings mainly refers to the number of times the same type of drug is marked, which is mainly obtained by counting the number of marking signals. Here, the number of drug markings for a drug type can be a count of all drugs in a certain area. The size of the area can be divided according to the area of ​​the actual area. The preset number represents the minimum number of markings that the drug type needs to be detected. The preset number is set in advance. In this embodiment, the preset number can preferably be set to 10 times. The detection signal characterization is used to detect whether there is a signal that needs to be detected for the drug type.

[0053] Specifically, the drug purchase detection module 40 is used to generate a marking signal based on marking the drug type, and the drug monitoring module 50 is connected to the drug purchase detection module 40 network to receive the marking signal of the drug type. The drug monitoring module 50 is used to identify the drug type in the marking signal based on the marking signal, and obtain the drug marking times of each drug type, and compare the drug marking times in turn to see if they exceed the preset times. If the drug marking times exceed the preset times, the drug monitoring module 50 generates a detection signal, and reminds the staff to detect the drug type based on the detection signal. If the drug marking times do not exceed the preset times, the drug monitoring module 50 does not perform any operation.

[0054] The implementation principle is: The data storage module 10 is used to store several groups of control user information and medical insurance data corresponding to the control user information. The fixed-point management module 20 is connected to the data storage module 10 through a network to obtain the control user information and medical insurance data. The data comparison unit 21 screens the drug purchasing user information in the control user information and determines whether the matching control user information can be screened. If the corresponding control user information cannot be matched, the data storage unit 22 obtains the demand information based on the drug purchasing user information, obtains the drug purchase type based on the demand information, and records and stores the drug purchase type. If the corresponding control user can be matched, the list processing unit 23 obtains the corresponding medical insurance data based on the control user information, obtains the demand information based on the drug purchasing user information, and obtains the contraindicated drug information based on the demand information based on the medical insurance data, and generates a compliant drug list based on the contraindicated drug information. The data display module 30 is connected to the fixed-point management module 20 through a network to receive the compliant drug list, and the data display module 30 is used to display the compliant drug list to the monitoring personnel in a graphical interface.

[0055] The embodiment of the present application also discloses an intelligent supervision method based on medical insurance data.

[0056] Reference Figure 4 , ,The intelligent supervision method based on medical insurance data includes the following steps: S100, obtaining drug purchasing user information, screening the drug purchasing user information in reference user information, and determining whether matching reference user information can be screened out.

[0057] S200, if the corresponding control user can be matched, the corresponding medical insurance data is obtained according to the control user information, the demand information is obtained according to the drug purchasing user information, and a list of compliant drugs is generated according to the demand information and the medical insurance data.

[0058] S300, displays the list of compliant drugs to monitoring personnel in a graphical interface.

[0059] It should be noted here that the comparison user information, medical insurance data, drug purchasing user information, demand information and compliant drug list are the same or similar to the description in the intelligent supervision system based on medical insurance data, so no further elaboration will be given here.

[0060] In addition, the method of obtaining the list of compliant drugs and the handling method when the corresponding control user cannot be matched are the same or similar to those described in the intelligent supervision system based on medical insurance data, and will not be elaborated here.

[0061] Specifically, the data storage module 10 is used to store several groups of control user information and medical insurance data corresponding to the control user information. The fixed-point management module 20 is connected to the data storage module 10 through a network to obtain the control user information and medical insurance data. The fixed-point management module 20 is used to obtain the drug purchasing user information, filter the drug purchasing user information in the control user information, and determine whether the matching control user information can be filtered out. If the corresponding control user can be matched, the corresponding medical insurance data is obtained based on the control user information, and the demand information is obtained based on the drug purchasing user information, and a list of compliant drugs is generated based on the demand information and the medical insurance data. The data display module 30 is connected to the fixed-point management module 20 through a network to receive the compliant drug list. The data display module 30 is used to display the compliant drug list to the monitoring personnel in a graphical interface.

[0062] Reference Figure 5 In another embodiment, for pharmacies, it is possible to estimate the drug consumption in advance and replenish the drugs in time, which can improve the service level and quality of the pharmacies to a greater extent and facilitate the general public to seek medical treatment and purchase drugs.

[0063] After obtaining the drug type that matches the drug purchasing user based on the compliant drug list, the following steps are also included: S400, regularly obtaining drug storage data corresponding to a number of drug types.

[0064] S500, obtaining estimated sales data based on a preset analysis model, obtaining estimated drug inventory based on the estimated sales data and drug storage data, and comparing the estimated drug inventory with the preset inventory.

[0065] S600: If the estimated drug inventory is less than the preset inventory, a corresponding purchase signal is generated so that the drug store to be tested can increase the drug storage data of the corresponding drug type according to the purchase signal.

[0066] Among them, drug storage data represents the storage volume of a drug in a pharmacy, and the preset analysis model represents a drug model built in advance. By inputting the drug name into the preset analysis model, the estimated sales volume of the drug can be obtained. The estimated sales data represents the upcoming sales volume of the drug, and the estimated drug inventory represents the difference between the estimated sales data and the drug storage data, that is, the estimated inventory of the drug. The purchase signal represents the purchase signal corresponding to the drug, which is mainly used to remind pharmacy staff that the drug needs to be purchased.

[0067] Specifically, the fixed-point management module 20 regularly obtains drug storage data corresponding to several drug types. Estimated sales data is obtained based on the preset analysis model, and the estimated drug inventory is obtained based on the estimated sales data and drug storage data, and the estimated drug inventory is compared with the preset inventory. If the estimated drug inventory is less than the preset inventory, the fixed-point management module 20 generates a corresponding purchase signal so that the pharmacy to be tested increases the drug storage data of the corresponding drug type based on the purchase signal. If the estimated drug inventory is not less than the preset inventory, the fixed-point management module 20 does not perform any operation, and the drugs of this drug type do not need to be purchased in advance.

[0068] It should be noted here that the preset analysis model is a model built through the historical drug sales data of the pharmacy to be tested, which can predict the actual sales of each drug in the pharmacy to be tested. The generation method of the preset analysis model is mainly built through the historical drug sales data corresponding to the pharmacy to be tested. The method used here is mainly the existing technology, so I will not go into details here.

[0069] In addition, for the periodic acquisition of drug storage data corresponding to several drug types, a specified period can be used, or a variable period can be used according to the drug sales situation of the pharmacy. Specifically, for some pharmacies where the drug sales situation is very stable, a specified period can be used, and the size of the specified period can be set according to the actual situation. In this embodiment, the specified period is preferably set to one week. For some pharmacies with unstable drug sales, sometimes too much and sometimes too little, a variable period can be used, and the setting of the variable period is specifically set according to the drug sales data of the pharmacy.

[0070] In another embodiment, in order to improve the service level and quality of the pharmacy and facilitate the general public to seek medical treatment and purchase medicines, it is necessary to always pay attention to the demand for medicines by people around the pharmacy, to promptly identify the physical conditions of surrounding users, to promptly discover unexpected events, and thus improve the medical efficiency of residents around the pharmacy.

[0071] After periodically obtaining the drug storage data corresponding to a number of drug types, the following steps are also included: S700, sequentially obtain the actual sales volume corresponding to the drug type, obtain the difference data quantity based on the actual sales volume and the estimated sales data, and determine whether the difference data quantity is greater than the preset data quantity.

[0072] S800, if the number of difference data is greater than the preset number of data, obtaining the treatment disease according to the drug type corresponding to the actual sales volume, and generating a corresponding symptomatic replenishment signal according to the treatment disease, so as to obtain several symptomatic drug types according to the symptomatic replenishment signal.

[0073] Among them, the actual sales volume represents the actual sales quantity corresponding to the drug type, the number of difference data represents the difference between the actual sales volume and the estimated sales data, and the number of preset data represents the minimum difference quantity that the drug type can sell. The treatment disease represents the symptoms that the drug type can treat, and the symptomatic replenishment signal represents the signal generated based on the treatment disease. Unlike the purchase signal, the symptomatic replenishment signal is a signal that the drug that solves the treatment disease needs to be replenished, and the symptomatic replenishment signal includes several types of drugs, while the purchase signal is a signal that a single drug type in the pharmacy needs to be replenished. Symptomatic drug types include several types of drugs, mainly drugs that can be used to symptomatically treat diseases.

[0074] Specifically, the fixed-point management module 20 sequentially obtains the actual sales volume corresponding to the drug type, obtains the difference data quantity based on the actual sales volume and the estimated sales data, and determines whether the difference data quantity is greater than the preset data quantity. If the difference data quantity is greater than the preset data quantity, the treatment disease is obtained according to the drug type corresponding to the actual sales volume, and a corresponding symptomatic replenishment signal is generated according to the treatment disease, so as to obtain several symptomatic drug types according to the symptomatic replenishment signal. If the difference data quantity is not greater than the preset data quantity, the fixed-point management module 20 does not perform any operation.

[0075] The embodiment of the present application also discloses an electronic device.

[0076] Reference Figure 6 The electronic device includes a memory 61 and a processor 62 coupled to each other, and the memory 61 stores a computer program 621 that can be run on the processor 62. When the computer program 621 is executed by the processor 62, an intelligent supervision method based on medical insurance data is implemented.

[0077] It should be understood that although the steps in the flowchart of the accompanying drawings are shown in sequence according to the instructions of the arrows, these steps are not necessarily performed in the order indicated by the arrows. Unless otherwise clearly stated in this document, the execution of these steps is not strictly limited in order and can be performed in other orders.

[0078] The above are all preferred embodiments of the present application, and the protection scope of the present application is not limited thereto. Therefore, any equivalent changes made according to the structure, shape, and principle of the present application should be included in the protection scope of the present application.

Claims

1. An intelligent supervision system based on medical insurance data, characterized in that: include: A data storage module (10), the data storage module (10) being used to store a plurality of groups of control user information and medical insurance data corresponding to the control user information; A fixed-point management module (20), the fixed-point management module (20) being connected to the data storage module (10) via a network to obtain the control user information and the medical insurance data, the fixed-point management module (20) being used to obtain drug purchasing user information, screen the drug purchasing user information in the control user information, and determine whether matching control user information can be screened; If a corresponding control user can be matched, the corresponding medical insurance data is obtained according to the control user information, and the demand information is obtained according to the drug purchasing user information, and a list of compliant drugs is generated according to the demand information and the medical insurance data; A data display module (30), the data display module (30) is connected to the fixed-point management module (20) through a network to receive the compliant drug list, and the data display module (30) is used to display the compliant drug list to monitoring personnel in a graphical interface.

2. The intelligent supervision system based on medical insurance data according to claim 1 is characterized in that: It also includes a drug purchase detection module (40), the drug purchase detection module (40) is connected to the fixed-point management module (20) via a network to receive the compliant drug list, the drug purchase detection module (40) is used to sequentially obtain temporary drug purchase data based on the compliant drug list, obtain previous drug purchase data corresponding to the user information, and determine whether the previous drug purchase data is similar to the temporary drug purchase data; If the previous drug purchase data is similar to the temporary drug purchase data, the drug purchase interval is obtained based on the previous drug purchase data and the temporary drug purchase data, and it is determined whether the drug purchase interval is within a preset range. If the drug purchase interval is within the preset range, it is determined that the drug type corresponding to the temporary drug purchase data is not effective, the drug type is marked, and it is automatically removed from the compliant drug list.

3. The intelligent supervision system based on medical insurance data according to claim 2 is characterized in that: It also includes a drug monitoring module (50), the drug purchase detection module (40) is further used to generate a marking signal based on marking the drug type, and the drug monitoring module (50) is connected to the drug purchase detection module (40) via a network to receive the marking signal of the drug type; The drug monitoring module (50) is used to obtain a number of drug types marked by the drug purchase detection module (40) according to the marking signal, and obtain the drug marking times of each drug type, and compare the drug marking times in turn to see whether they exceed a preset number; If the number of times the drug is marked exceeds a preset number, the drug monitoring module (50) generates a detection signal, and reminds the staff to test the drug type according to the detection signal.

4. The intelligent supervision system based on medical insurance data according to claim 1 is characterized in that: The fixed-point management module (20) comprises a data comparison unit (21), a data storage unit (22) and a list processing unit (23), wherein the data comparison unit (21) is connected to the data storage unit (22) via a network, and the data comparison unit (21) is connected to the list processing unit (23) via a network; The data comparison unit (21) screens the drug purchasing user information in the control user information and determines whether matching control user information can be screened out; If the corresponding control user information cannot be matched, the data storage unit (22) obtains the demand information according to the drug purchasing user information, obtains the drug purchasing type according to the demand information, and records and stores the drug purchasing type; If a corresponding control user can be matched, the list processing unit (23) obtains the corresponding medical insurance data based on the control user information, obtains the demand information based on the drug purchasing user information, and obtains the contraindicated drug information based on the demand information based on the medical insurance data, and generates the compliant drug list based on the contraindicated drug information.

5. The intelligent supervision system based on medical insurance data according to claim 4 is characterized in that: The fixed-point management module (20) further comprises a fee control unit (24) and a first warning unit (25) connected to the fee control unit (24) through a network; The cost control unit (24) is connected to the list processing unit (23) via a network to receive the compliant drug list and obtain corresponding drug price information, compare the price value of the drug price information with the corresponding preset price, and determine whether the price value is similar to the preset price; If the price value is not similar to the preset price, the first warning unit (25) generates a warning signal and sends an abnormal instruction according to the warning signal to remind the monitoring personnel.

6. The intelligent supervision system based on medical insurance data according to claim 4 is characterized in that: The fixed-point management module (20) further comprises a drug purchase analysis unit (26) and a second warning unit (27) connected to the drug purchase analysis unit (26) through a network; The drug purchase analysis unit (26) is used to obtain all the treatment diseases corresponding to the area to be tested, and the area to be tested includes a number of drug stores to be tested; Obtaining the number of pharmacies to be tested according to the treatment disease, and comparing the number of pharmacies to be tested with a preset number, wherein the number of pharmacies to be tested represents the number of pharmacies to be tested that have the same treatment disease; Analyze the environmental conditions of all the pharmacies to be tested to obtain the environmental type, and determine whether all the pharmacies to be tested are in the same environment; If all the pharmacies to be tested are in the same environment, the second warning unit (27) generates a first response signal and performs a first level of protection according to the first response signal; If all the pharmacies to be tested are not in the same type of environment, the second warning unit (27) generates a second response signal and performs secondary protection according to the second response signal.

7. An intelligent supervision method based on medical insurance data, characterized in that: The following steps are involved: Acquire drug purchasing user information, filter the drug purchasing user information in the control user information, and determine whether matching control user information can be found; If a corresponding control user can be matched, the corresponding medical insurance data is obtained according to the control user information, and the demand information is obtained according to the drug purchasing user information, and a list of compliant drugs is generated according to the demand information and the medical insurance data; The list of compliant drugs and the types of purchased drugs are displayed to monitoring personnel in a graphical interface.

8. The intelligent supervision method based on medical insurance data according to claim 7 is characterized in that: After obtaining the drug type matching the drug purchasing user according to the compliant drug list, the following steps are also included: Regularly obtain drug storage data corresponding to a number of drug types; Obtaining estimated sales data based on a preset analysis model, obtaining estimated drug inventory based on the estimated sales data and the drug storage data, and comparing the estimated drug inventory with a preset inventory; If the estimated drug inventory is less than the preset inventory, a corresponding purchase signal is generated so that the drug store to be tested increases the drug storage data of the corresponding drug type according to the purchase signal.

9. The intelligent supervision method based on medical insurance data according to claim 8 is characterized in that: After the step of regularly acquiring the drug storage data corresponding to the drug types, the following steps are also included: Obtaining the actual sales volume corresponding to the drug type in sequence, and obtaining the difference data quantity according to the actual sales volume and the estimated sales data, and determining whether the difference data quantity is greater than the preset data quantity; If the number of difference data is greater than the preset number of data, the treatment condition is obtained according to the drug type corresponding to the actual sales volume, and a corresponding symptomatic replenishment signal is generated according to the treatment condition, so as to obtain several symptomatic drug types according to the symptomatic replenishment signal.

10. An electronic device, characterized in that: The electronic device comprises a memory (61) and a processor (62) coupled to each other, wherein the memory (61) stores a computer program (621) that can be run on the processor (62); When the computer program (621) is executed by the processor (62), the intelligent supervision method based on medical insurance data as described in any one of claims 7 to 9 is implemented.

Citation Information

Cited By

  • Intelligent business supervision and behavior tracing system and method based on data driving

    CN121304354A

  • Data-driven business intelligence supervision and behavior tracing system and method

    CN121304354B